“Zanolimumab (Humax-CD4), a Fully Human Monoclonal Antibody With Significant Clinical Responses in Cutaneous T-Cell Lymphoma”. 2009. Hematology Meeting Reports (formerly Haematologica Reports) 3 (1). https://doi.org/10.4081/hmr.v3i1.540.